Skip to main content
. Author manuscript; available in PMC: 2022 Apr 17.
Published in final edited form as: Neuroreport. 2013 Jan 9;24(1):36–40. doi: 10.1097/WNR.0b013e32835c1de4

Figure 3: Effect of PAR activating peptides on chemokine release.

Figure 3:

Human fetal astrocytes were stimulated with indicated concentrations of PAR1 agonist peptide (PAR1 AP), PAR1 scrambled peptide (PAR1ScrP) or PAR4 agonist peptide (PAR4 AP). IL-8 (A) and IP-10 (B) release was assessed 24 h later in conditioned medium as described in Methods. Data are expressed as mean ± S.E.M. percent response relative to thrombin plus DMSO (vehicle) control. n≥6, exp≥2, * indicates p< 0.05, ** indicates p< 0.01.